Is Renal Thrombotic Angiopathy an Emerging Problem in the Treatment of Ovarian Cancer Recurrences?

Learning Objectives After completing this course, the reader will be able to: Describe the need for additional vigilance regarding renal dysfunction when platinums, pegylated liposomal doxorubicin, bevacizumab, and gemcitabine are used for prolonged treatment of recurrent ovarian cancer in combinati...

Full description

Saved in:

Bibliographic Details
Published in:	The oncologist (Dayton, Ohio) Vol. 17; no. 12; pp. 1534 - 1540
Main Authors:	Kwa, Maryann, Baumgartner, Robert, Shavit, Linda, Barash, Irina, Michael, Jeffrey, Puzanov, Igor, Kopolovic, Juri, Rosengarten, Ora, Blank, Stephanie, Curtin, John P., Gabizon, Alberto, Muggia, Franco
Format:	Journal Article
Language:	English
Published:	Durham, NC, USA AlphaMed Press 01.12.2012
Subjects:	Adult Aged Antibodies, Monoclonal, Humanized - administration & dosage Antibodies, Monoclonal, Humanized - adverse effects Bevacizumab Chronic kidney disease Creatinine - blood Deoxycytidine - administration & dosage Deoxycytidine - adverse effects Deoxycytidine - analogs & derivatives Doxorubicin - administration & dosage Doxorubicin - adverse effects Doxorubicin - analogs & derivatives Fatal Outcome Female Gynecologic Oncology Humans Middle Aged Ovarian cancer Ovarian Neoplasms - complications Ovarian Neoplasms - drug therapy Ovarian Neoplasms - pathology Pegylated liposomal doxorubicin Platinum - therapeutic use Polyethylene Glycols - administration & dosage Polyethylene Glycols - adverse effects Quality of Life Recurrence Renal Insufficiency, Chronic - etiology Renal Insufficiency, Chronic - pathology Renal thrombotic microangiopathy Retrospective Studies Risk Factors Taxoids - therapeutic use Thrombosis - etiology Thrombosis - pathology Topotecan - administration & dosage Topotecan - adverse effects
ISSN:	1083-7159, 1549-490X, 1549-490X
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!